20,139 Shares in Lam Research Corporation $LRCX Bought by Denali Advisors LLC

Key Points

• Denali Advisors acquired 20,139 Lam Research shares during the second quarter, worth approximately $8.73 million and representing 0.9% of its portfolio. Institutional investors collectively own 84.61% of LRCX.
• Lam Research reported strong quarterly results, with revenue up 30% year over year to $6.72 billion and EPS of $1.82, exceeding analyst expectations. The company expects AI-related semiconductor demand to support growth through 2027 and plans to invest more than $3 billion in research and development over five years.
• Analysts maintain a broadly positive view, with a consensus “Moderate Buy” rating and a $357.31 price target, although Mizuho slightly reduced its target. Risks include LRCX’s elevated valuation, recent insider selling, and broader pressure on semiconductor stocks.

Denali Advisors LLC acquired a new stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 20,139 shares of the semiconductor company's stock, valued at approximately $8,727,000. Lam Research comprises 0.9% of Denali Advisors LLC's portfolio, making the stock its 22nd largest holding.

A number of other hedge funds have also bought and sold shares of the company. Bayban bought a new stake in Lam Research in the fourth quarter worth about $26,000. Vermillion Wealth Management Inc. bought a new position in shares of Lam Research during the first quarter valued at approximately $26,000. Cedar Mountain Advisors LLC grew its stake in shares of Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after buying an additional 85 shares during the last quarter. Paladin Partners LLC purchased a new stake in shares of Lam Research in the second quarter worth approximately $26,000. Finally, Mcguire Capital Advisors Inc. purchased a new stake in shares of Lam Research in the fourth quarter worth approximately $27,000. Institutional investors own 84.61% of the company's stock.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI-driven growth outlook: Reports indicate Lam Research expects strong growth to extend into 2027 as artificial-intelligence spending supports demand for semiconductor manufacturing equipment. The company’s recent earnings also showed momentum, with revenue rising 30% year over year and EPS exceeding analyst expectations.
• Positive Sentiment: Analyst remains bullish: Mizuho lowered its price target modestly from $370 to $365 but maintained an “outperform” rating, implying substantial upside from the referenced price. Wall Street coverage broadly remains supportive of Lam Research’s growth prospects. Benzinga
• Positive Sentiment: Investment in research and development: Lam Research plans to invest more than $3 billion over five years to expand its global R&D laboratory network and increase experimentation capacity. The spending could strengthen its technology pipeline and competitive position as chipmakers invest in advanced manufacturing. Lam Research R&D update
• Neutral Sentiment: Short-interest data offers no signal: Reported short interest was zero shares both periods, producing a zero-day short ratio. Because the data shows no measurable short position, it does not provide a meaningful indication of potential buying pressure or bearish sentiment.
• Negative Sentiment: Sector-wide pressure: Semiconductor stocks declined ahead of NVIDIA’s earnings report, reflecting investor de-risking and sensitivity to AI-related expectations. Weakness across chip equipment and foundry shares could weigh on LRCX despite its company-specific growth outlook. Semiconductor stocks slide
• Negative Sentiment: Valuation and target reduction: LRCX trades at a relatively elevated earnings multiple, while Mizuho’s target-price cut signals some caution about near-term upside even though its rating remains positive.

Lam Research Stock Up 1.4%

Shares of NASDAQ:LRCX opened at $314.66 on Wednesday. The business's 50 day moving average is $334.80 and its 200 day moving average is $287.73. The stock has a market cap of $393.74 billion, a P/E ratio of 54.63, a price-to-earnings-growth ratio of 1.23 and a beta of 1.84. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating analysts' consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. During the same period in the previous year, the company posted $1.33 EPS. Lam Research's revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Sell-side analysts predict that Lam Research Corporation will post 9.32 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on LRCX. HSBC restated a "hold" rating and set a $333.00 price objective on shares of Lam Research in a report on Monday, July 27th. Cantor Fitzgerald set a $500.00 target price on Lam Research and gave the stock an "overweight" rating in a research report on Monday, June 29th. Stifel Nicolaus boosted their target price on shares of Lam Research from $325.00 to $425.00 and gave the company a "buy" rating in a research note on Friday, July 10th. Susquehanna restated a "positive" rating and issued a $475.00 price target (up from $385.00) on shares of Lam Research in a report on Tuesday, June 30th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $390.00 price target on shares of Lam Research in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $357.31.

Insider Buying and Selling

In other Lam Research news, SVP Neil J. Fernandes sold 7,659 shares of the firm's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president owned 58,470 shares of the company's stock, valued at approximately $18,102,312. This trade represents a 11.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the business's stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director owned 87,142 shares of the company's stock, valued at approximately $29,192,570. This represents a 17.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 80,441 shares of company stock valued at $27,614,296 over the last three months. 0.31% of the stock is owned by company insiders.

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source